698982-14-8

Basic information

• Product Name: [3-(4-bromo-2-methoxyphenyl)-4,5-dihydroisoxazol-5-yl]methanol
• Synonyms: [3-(4-bromo-2-methoxyphenyl)-4,5-dihydroisoxazol-5-yl]methanol
• CAS NO: 698982-14-8
• Molecular Weight: 286.125
• Mol File: 698982-14-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: [3-(4-bromo-2-methoxyphenyl)-4,5-dihydroisoxazol-5-yl]methanol(CAS DataBase Reference)
• NIST Chemistry Reference: [3-(4-bromo-2-methoxyphenyl)-4,5-dihydroisoxazol-5-yl]methanol(698982-14-8)
• EPA Substance Registry System: [3-(4-bromo-2-methoxyphenyl)-4,5-dihydroisoxazol-5-yl]methanol(698982-14-8)

Safety Data

• Hazardous Substances Data: 698982-14-8(Hazardous Substances Data)

Upstream product

• 698982-08-0 4-bromo-2-methoxybenzaldehyde oxime 
• 107-18-6 allyl alcohol 
• 43192-33-2 4-bromo-2-methoxybenzaldehyde 
• 22532-62-3 4-bromosalicylaldehyde 

Downstream Products

• 698982-20-6 3-(4-bromo-2-methoxyphenyl)-5-({[tert-butyl(dimethyl)silyl]oxy}methyl)-4,5-dihydroisoxazole 
• 698981-89-4 (5R)-3-{2-fluoro-4`-[5-(hydroxymethyl)-4,5-dihydroisoxazol-3-yl]-3`-methoxy-1,1`-biphenyl-4-yl}-5-(1H-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-one 
• 698982-26-2 5-({[tert-butyl(dimethyl)silyl]oxy}methyl)-3-[2-methoxy-4-(trimethylstannyl)phenyl]-4,5-dihydroisoxazole 
• 698981-84-9 (5R)-3-{4'-[5-({[tert-butyl(dimethyl)silyl]oxy}methyl)-4,5-dihydroisoxazol-3-yl]-2-fluoro-3`-methoxy-1,1`-biphenyl-4-yl}-5-(1H-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-one 

Relevant articles and documents

ANTIBACTERIAL COMPOUNDS

A compound of the formula (I), or a pharmaceutically-acceptable salt, or in-vivo hydrolysable ester thereof wherein in (I) C is for example formula (D), (E), (H) wherein A and B are independently selected from formulae (i) and (ii) and R2b and R6b, R2b and R6a, R3a and R5a, are for example selected from H, F, OMe and Me; R2b’ and R6b’, R2a’ and R6a’, R3a’, R5a’ are for example selected from H, OMe and Me; R1a and R1b are for example selected from hydroxy, -OSi(tri-(1-6C)alkyl), NR5C(=W) R4, formla (a), formula (b) wherein HET-1 is for example isoxazolyl and HET-2 is for example triazolyl or tetrazolyl. Methods for making compounds of the formula (I), compositions containing them and their use as antibacterial agents are also described.